Federal Cervical Cancer Collaborative

Health provider in blue medical gloves holding vaginal speculum

Problem

Cervical cancer is preventable and treatable, but treatment and outcome differences persist.

Cervical cancer is largely preventable through vaccination and highly treatable when caught early through routine screening. But despite innovations in cancer prevention, early detection, and treatment, there are still substantial differences in screening and cervical cancer death rates. Safety-net health care settings provide critical cervical cancer care in terms of both prevention and screening. This means it is critical that safety-net providers are implementing evidence-based prevention, screening, and management guidelines when caring for their patients.

Solution

NORC convened experts to identify solutions.

The Federal Cervical Cancer Collaborative is an offshoot of the Cancer Moonshot, which seeks to realize the aims of the moonshot and support uptake of innovations. NORC supported the FCCC by convening experts across the U.S. and U.S. territories, including providers, advocates, academics, and federal employees in a roundtable meeting series to identify solutions and promising practices to address barriers to cervical cancer prevention and early detection.

Result

NORC created resources to promote prevention, screening, and management.

NORC translated insights from the roundtable series to inform two products:

The Toolkit to Build Provider Capacity is a practical resource designed to help safety-net care providers adopt and maintain evidence-based practices to increase uptake and improve practices related to HPV vaccination, cervical cancer screening, and management after an abnormal screening. The toolkit includes resources and interventions to address common barriers to cervical cancer prevention and early detection at the patient and provider level.

The Federal Opportunities Report identifies areas where federal collaboration may address structural barriers that are larger than the safety-net setting. It identifies opportunities related to promoting HPV vaccination and cervical cancer screening and strengthening collaboration and communication to support these efforts.